Clinical Trial: A Study of the Synergistic Effect of Vebecototumab Combined with Bevacizumab in Conjunction with Re-radiotherapy for the Treatment of Recurrent High-Grade Brain Gliomas (China)

Posted On: 2026-08-19

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of the Synergistic Effect of Vebecototumab Combined with Bevacizumab in Conjunction with Re-radiotherapy for the Treatment of Recurrent High-Grade Brain Gliomas'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130332

Registration Time: 2026/08/18

Type: Interventional study

Primary Sponsor: Anhui Provincial Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337300

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Study of the Synergistic Effect of Vebecototumab Combined with Bevacizumab in Conjunction with Re-radiotherapy for the Treatment of Recurrent High-Grade Brain Gliomas (China)